Skip to main content

Screening foreign-born adults for chronic hepatitis B

CBE ID
0402
Endorsed
Endorsement Status
1.1 New or Maintenance
E&M Cycle
Is Under Review
No
1.3 Measure Description

Percentage of adults aged 18 years and above born in an HBV-endemic country and tested for hepatitis B surface antigen and antibody

        • 1.14 Numerator

          Number of adults aged 18 years and above, born in a hepatiits B virus (HBV)-endemic country, with serological test results for hepatitis B surface antigen (HBsAg) and hepatitis B surface antibody (anti-HBs) during adulthood documented in the medical record; calculated annually on a per-facility basis

        • 1.15 Denominator

          Number of adults aged 18 years and above, born in a country with intermediate or high HBV endemicity (all African countries; all East Asian countries; all East European and North Asian countries except Hungary; all South Asian countries except Sri Lanka; all Southeast Asian countries; all South Pacific countries and territories except Australia and New Zealand; all Middle Eastern countries except Cyprus; also, Greece, Malta, Portugal, Spain, Greenland natives, Alaska natives, North Canada indigenous populations, Argentina, Bolivia, Brazil, Ecuador, Guyana, Suriname, Venezuela, Amazonian areas of Colombia and Peru, Antigua and Barbuda, Dominica, Dominican Republic, Grenada, Haiti, Jamaica, Puerto Rico, St. Kitts and Nevis, St. Lucia, St. Vincent and Grenadines, Trinidad and Tobaco, and Turcs and Caicos; see CDC, 2006 p.7); calculated annually on a per-facility basis

        • Exclusions

          None

        • Most Recent Endorsement Activity
          Measure Retired and Endorsement Removed Clinician-Level Infectious Disease Management
          Initial Endorsement
          Last Updated
          Removal Date